LLA.L,0P0001T9GN,0

LLA.L

LLA.LLLA.L,0P0001T9GN,0 GB flag

London Stock Exchange

15.00

GBp

- -

-0.13EPS

-1.15P/E

3.82MMarket Cap

ISIN

USU5500L1128

Return %

Stock

S&P500

4,900.00

31.25

4,900.00

33.75

4,900.00

93.35

Use logarithmic scale

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Revenue per Share	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -
Sales/Revenue/Turnover	1	- -	- -	- -	- -	- -
Operating Margin (%)	-229.73	-2,499.93	-1,815.3	-2,740.51	-29,683.33	-12,560.87
Depreciation Expense	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-3	-4	-5	-7	-8	-5
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-330.92	-3,060.76	-2,358.43	-3,817.44	-31,691.67	-11,767.39
Working Capital	-1	-7	-12	14	7	2
LT Debt	3	- -	- -	1	- -	- -
Total Equity	-3	-7	-11	20	13	8
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	-7.35%	91.67%
Net Income, GAAP	- -	14.31%	-28.83%
Free Cash Flow	- -	43.76%	-14.05%
Total Cash Common Dividend	- -	- -	- -
Total Equity	- -	-33.39%	-39.78%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Dr. Paul Pagano Ph.D.
Full Time Employees: 8
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Address: 2545 West Hillcrest Drive Thousand Oaks CA United States of America 91320
IPO Date: Jun 26, 2024
Website: lunglifeai.com
Similar Companies: Pacific Edge Limited (PEB.NZ)
Diagnósticos da América S.A. (DASA3.SA)
H.U. Group Holdings, Inc. (4544.T)
IDenta Corp. (IDTA)
Selvita S.A. (SLV.WA)
Sonic Healthcare Limited (SHL.AX)
Business: LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.

	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Revenue per Share	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -
Sales/Revenue/Turnover	1	- -	- -	- -	- -	- -
Operating Margin (%)	-229.73	-2,499.93	-1,815.3	-2,740.51	-29,683.33	-12,560.87
Depreciation Expense	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-3	-4	-5	-7	-8	-5
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-330.92	-3,060.76	-2,358.43	-3,817.44	-31,691.67	-11,767.39
Working Capital	-1	-7	-12	14	7	2
LT Debt	3	- -	- -	1	- -	- -
Total Equity	-3	-7	-11	20	13	8
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -
Return on Capital (%)	- -	- -	- -	- -	- -	- -
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -

LLA.L,0P0001T9GN,0

Growth Rates

(avg. rate of change)

Company Description

Capital Structure

Working Capital

Growth Rates

(avg. rate of change)

Quarterly Earnings Per Share

Year

Quarterly Revenue

Year

Quarterly Dividends Per Share

Year